Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Return on Sales (2016 - 2021)

GT Biopharma (GTBP) has disclosed Return on Sales for 10 consecutive years, with 827.27% as the latest value for Q4 2021.

  • On a quarterly basis, Return on Sales changed N/A to 827.27% in Q4 2021 year-over-year; TTM through Dec 2021 was 2645.5%, a N/A change, with the full-year FY2025 number at 97.84%, changed N/A from a year prior.
  • Return on Sales was 827.27% for Q4 2021 at GT Biopharma, up from 4.1% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 827.27% in Q4 2021 to a low of 11.55% in Q2 2020.
  • A 4-year average of 157.45% and a median of 5.82% in 2019 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was -1738bps in 2020; the steepest drop was -24245bps in 2020.
  • GT Biopharma's Return on Sales stood at 209.96% in 2018, then crashed by -100bps to 0.41% in 2019, then crashed by -909bps to 4.1% in 2020, then soared by 20295bps to 827.27% in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Return on Sales are 827.27% (Q4 2021), 4.1% (Q3 2020), and 11.55% (Q2 2020).